Can Fite Biopharma
CANF
$1.97
Share price
0.51%
Change (1 day)
9.44%
Change (1 year)
Categories
P/S ratio for Can Fite Biopharma (CANF)
P/S ratio as of April 2024 (TTM): 14.0
According to Can Fite Biopharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.0094. At the end of 2023 the company had a P/S ratio of 18.9.
P/S ratio history for Can Fite Biopharma from 2012 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 18.9 | -16.2% |
| 2022 | 22.5 | -40.56% |
| 2021 | 37.9 | 1.2% |
| 2020 | 37.5 | 484.11% |
| 2019 | 6.41 | -1.6% |
| 2018 | 6.52 | -77.8% |
| 2017 | 29.4 | -84.91% |
| 2016 | 195 | -21.39% |
| 2015 | 247 | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A |